Board of Trustees
Professor T.M. Cox is the Chairman of the Croucher Foundation and Emeritus Professor of Medicine and Director of Research at the University of Cambridge from October 2015. Cox was elected Professor of Medicine at the University of Cambridge in 1988, and is an Honorary Consultant Physician at Addenbrooke’s NHS Foundation Trust Hospitals.
Professor Roland Chin is currently the President Emeritus in the Hong Kong Baptist University. Professor Chin joined HKBU as the fifth President and Vice-Chancellor from 2015 to 2020. He was Provost and Deputy Vice-Chancellor and Chair Professor of Computer Science of The University of Hong Kong from 2010 to 2015.
George Long is the Founder, Chairman and Chief Investment Officer of LIM Advisors Limited. His experience in the financial industry began in 1980. Before leaving to establish LIM, George set up and ran Barclays Global Investors' asset management business in Asia.
Josephine Price is director and co-founder of Anthem Asia Limited which is an independent investment group exploring business opportunities in Myanmar. Prior to Anthem she spent 13 years with CLSA Capital Partners where she co-founded CLSA’s pan-Asian private equity platform.
Professor Dennis Lo is the Director of the Li Ka Shing Institute of Health Sciences, the Li Ka Shing Professor of Medicine, and Professor of Chemical Pathology of The Chinese University of Hong Kong (CUHK).
Professor Vivian Yam is the Philip Wong Wilson Wong Professor in Chemistry and Energy at the University of Hong Kong. Yam is well known for her work in inorganic chemistry, organometallic chemistry, photochemistry, and photophysics.
Professor Artur Ekert (born in Wrocław, Poland) is a Professor of Quantum Physics at the Mathematical Institute, University of Oxford, and a Lee Kong Chian Centennial Professor at the National University of Singapore and also the Director of CQT (Centre for Quantum Technologies).
Sophia Zhu is Head of Compliance Assurance, APAC and Japan, Citigroup. She provides supervisory oversight for the compliance assurance activities of Citi’s APAC and Japan regions to monitor compliance with applicable rules, laws and regulations. Sophia is based in Hong Kong.
Sir Gregory is a molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research was conducted at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering in Cambridge, UK.